338 related articles for article (PubMed ID: 29503738)
1. Tissue-specific Role of CX
Lee M; Lee Y; Song J; Lee J; Chang SY
Immune Netw; 2018 Feb; 18(1):e5. PubMed ID: 29503738
[TBL] [Abstract][Full Text] [Related]
2. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer.
Lu X
Curr Med Chem; 2022; 29(41):6228-6246. PubMed ID: 35770395
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.
Park Y; Lee J; Kwak JY; Noh K; Yim E; Kim HK; Kim YJ; Broxmeyer HE; Kim JA
J Leukoc Biol; 2018 Jan; 103(1):53-66. PubMed ID: 28978662
[TBL] [Abstract][Full Text] [Related]
4. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
5. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1.
Nakayama T; Watanabe Y; Oiso N; Higuchi T; Shigeta A; Mizuguchi N; Katou F; Hashimoto K; Kawada A; Yoshie O
J Immunol; 2010 Dec; 185(11):6472-9. PubMed ID: 20974991
[TBL] [Abstract][Full Text] [Related]
6. C-X3-C motif chemokine ligand 1/receptor 1 regulates the M1 polarization and chemotaxis of macrophages after hypoxia/reoxygenation injury.
Guo S; Dong L; Li J; Chen Y; Yao Y; Zeng R; Shushakova N; Haller H; Xu G; Rong S
Chronic Dis Transl Med; 2021 Dec; 7(4):254-265. PubMed ID: 34786544
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.
Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR
Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082
[TBL] [Abstract][Full Text] [Related]
8. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.
Siddiqui I; Erreni M; van Brakel M; Debets R; Allavena P
J Immunother Cancer; 2016; 4():21. PubMed ID: 27096098
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine receptor chemokine (CX3CR1) influences on cervical and lumbar disc herniation.
Oh IS; Suh DW; Park SR; Ha KY
Indian J Orthop; 2015; 49(2):239-44. PubMed ID: 26015616
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
[TBL] [Abstract][Full Text] [Related]
11. Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue.
El-Shazly AE; Doloriert HC; Bisig B; Lefebvre PP; Delvenne P; Jacobs N
Clin Exp Allergy; 2013 Mar; 43(3):322-31. PubMed ID: 23414540
[TBL] [Abstract][Full Text] [Related]
12. CX3CL1 Signaling in the Tumor Microenvironment.
Conroy MJ; Lysaght J
Adv Exp Med Biol; 2020; 1231():1-12. PubMed ID: 32060841
[TBL] [Abstract][Full Text] [Related]
13. Defective antitumor responses in CX3CR1-deficient mice.
Yu YR; Fong AM; Combadiere C; Gao JL; Murphy PM; Patel DD
Int J Cancer; 2007 Jul; 121(2):316-22. PubMed ID: 17372897
[TBL] [Abstract][Full Text] [Related]
14. The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.
Nevo I; Sagi-Assif O; Meshel T; Ben-Baruch A; Jöhrer K; Greil R; Trejo LE; Kharenko O; Feinmesser M; Yron I; Witz IP
Cancer Lett; 2009 Jan; 273(1):127-39. PubMed ID: 18778890
[TBL] [Abstract][Full Text] [Related]
15. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis.
Helmke A; Nordlohne J; Balzer MS; Dong L; Rong S; Hiss M; Shushakova N; Haller H; von Vietinghoff S
Kidney Int; 2019 Jun; 95(6):1405-1417. PubMed ID: 30948201
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
[TBL] [Abstract][Full Text] [Related]
17. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
[TBL] [Abstract][Full Text] [Related]
18. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.
Erreni M; Siddiqui I; Marelli G; Grizzi F; Bianchi P; Morone D; Marchesi F; Celesti G; Pesce S; Doni A; Rumio C; Roncalli MG; Laghi L; Mantovani A; Allavena P
J Immunol; 2016 Jan; 196(2):902-14. PubMed ID: 26673138
[TBL] [Abstract][Full Text] [Related]
19. E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1
Wakita H; Yanagawa T; Kuboi Y; Imai T
Mol Pharmacol; 2017 Nov; 92(5):502-509. PubMed ID: 28842393
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia.
Ren J; Hou XY; Ma SH; Zhang FK; Zhen JH; Sun L; Sun YX; Hao YL; Cheng YF; Hou M; Xu CG; Zhang MH; Peng J
J Intern Med; 2014 Nov; 276(5):512-24. PubMed ID: 24528288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
